Today’s pharmaceutical landscape positions 'sustainability' as an operational imperative. Manufacturers face increasing regulatory, societal, and stakeholder pressure to demonstrate environmental responsibility. In essence, their Environmental Cost of Ownership (ECO) has become a critical performance metric - one that reflects not only the cost of purchasing and operating equipment but also the broader environmental impacts it generates throughout its lifecycle